Rate My Professor Ikram Shah bin Ismail

Ikram Shah bin Ismail's research spans molecular biology and endocrinology-related fields. His interests include diabetic retinopathy mechanisms, advanced glycation end products, β-adrenergic receptors agonists in hyperglycemic Müller cells, type 2 diabetes and hepatitis C virus associations, HIV treatment strategies and mortality, cancer prognosis models, and biomaterials like chitosan- and heparin-based hydrogels. Key publications co-authored by him are "Chitosan- and heparin-based advanced hydrogels: their chemistry, structure and biomedical applications" (Chemical Papers, 2024), "Mechanisms of β-adrenergic receptors agonists in mediating pro and anti-apoptotic pathways in hyperglycemic Müller cells" (Molecular Biology Reports, 2022), "Association of type 2 diabetes and hepatitis C virus infection in Pakistani population: A meta-analysis" (Songklanakarin Journal of Science and Technology, 2022), "Development and Validation of a Prognostic Nomogram Model for HER2-Positive Male Breast Cancer Patients" (Asian Pacific Journal of Cancer Prevention, 2024), "Relationship between LncRNA-MEG3 and Vascular Endothelial Cell Function" (Sarhad Journal of Agriculture, 2024), "Implementation of ‘Test and Treat’ Strategy: Analysis of Deaths of People Living with HIV from 2017 to 2022 in Baise City, China" (Archives of Clinical Infectious Diseases, 2024), and "Molecular Mechanisms of Diabetic Retinopathy, General Review and Novel Insights into the Role of Advanced Glycation End Products" (Journal of Diabetes Research, 2014).